Flaskdata Partner Program Member Corcos Makes Progress On Clinical Trial

The Israeli tech company Flaskdata.io that provides real-time clinical data collection and protocol monitoring automation for clinical trials anounced their partnership with Israeli boutique clinical and regulatory consultancy Corcos Clinical.

Corcos recently completed a complex clinical trial in three Israeli ICUs with an early stage medical device sponsor that selected the Flaskdata.io platform.

Yael Corcos, Managing Partner of Corcos, says, "We started as an early adopter of the Flaskdata.io eSource app in a challenging ICU environment. The Flaskdata.io team worked closely with us and the early adopter client to successfully complete the project. We are delighted to have the opportunity to use the Flaskdata.io platform in a new gastro medical device study, and we look forward to ramp-up clinical operations after release of COVID-19 social distancing constraints in the hospital sites."

A representative for Flaskdata.io says, “When we started Flaskdata, our aim was to push the clinical trials industry forward aand adopt digital automation for study monitoring. We set out with a goal to help life sciences companies complete their Phase 2 and Phase 3 clinical trials 3-6 months faster. Working with boutique clinical consultancies like Corcos and helping them in their clinical trials has been a high point of the work we do here at Flaskdata. It brings us no small amount of satisfaction to know that we have been able to help with innvovative medical research, and we are looking forward to continuing work with Yael Corcos and her company.”

The Flaskdata partner program is actively seeking business partners in the global life science clinical trials market. The company works primarily with four types of business partners. The first are customer developer partners, who have strong sales skills, deep knowledge and great access to a particular medical device vertical—for example, esthetics—and want to grow their revenue with Flaskdata.io’s innovative products for patient compliance automation. The second type of partners are CRO partners, who want to get an edge on the competition with innovative technology for eSource, ePRO, medical IoT integration and automated detection and response. The third category are embedded API partners who use the Flask API to create new applications running on mobile and desktop devices and medical IoT. Finally, the company works with design partners who gain early access to Flaskdata.io’s automated detection and response technology and will work with the company’s data science team to enrich and extend the capabilities of the Flask AI.

Flaskdata.io’s representative says, “The Israeli life science industry is special not only in its ground-breaking innovation but in not having a domestic market for its products. Without a domestic market, Israeli life science companies must innovate locally and work globally in their clinical research, manufacturing, sales and marketing. This creates an ideal proving ground for Flaskdata.io to develop battle-proven products for the global clinical trials monitoring industry. We collaborate with our partners to develop business—innovating locally and working globally.

“If you are a boutique consultancy that want to grow your business and work with a tech company that thinks differently about managing clinical trials, then we want to talk to you.”

Flaskdata provides a cloud platform for real-time clinical data collection and protocol monitoring automation that helps life science companies get interpretable data and save 3-6 months to study completion. For more information Contact Flaskdata.io.